Restoration of Hypoglycemia Awareness After Islet Transplantation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—To determine the impact of islet transplantation (ITx) on hypoglycemia awareness in patients with unstable type 1 diabetes and its relation to islet function. RESEARCH DESIGN AND METHODS—A total of 31 ITx recipients were studied. Hypoglycemia unawareness was assessed using the Clarke hypoglycemic score (0 = no hypoglycemia; ≥4 = hypoglycemia unawareness). Subjects were grouped based on graft function: off-insulin (n = 8), graft dysfunction (on-insulin and stimulated C-peptide ≥0.3 ng/ml, n = 13), and graft failure (stimulated C-peptide <0.3 ng/ml, n = 10, evaluated 11.5 ± 14.5 months after graft failure). RESULTS—The hypoglycemia score improved after ITx when compared with baseline values (before vs. after: 5.29 ± 1.51 vs. 1.35 ± 1.92, P < 0.001). This result was sustained even after patient stratification based on islet function (pre vs. post off-insulin: 5.63 ± 2.00 vs. no hypoglycemia reported; graft dysfunction: 5.31 ± 1.49 vs. 1.15 ± 1.63, P < 0.001; and graft failure: 5.00 ± 1.16 vs. 2.70 ± 2.26, P = 0.014). CONCLUSIONS—The improved metabolic control achieved with ITx can restore hypoglycemia awareness in patients with type 1 diabetes, persisting even after islet graft failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, successful transplantation of whole pancreata or isolated pancreatic islet cells in patients with type 1 diabetes (116 -118) results in marked improvements in glycemic control and near abolition of iatrogenic hypoglycemia.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [116]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, successful transplantation of whole pancreata or isolated pancreatic islet cells in patients with type 1 diabetes (116–118) results in marked improvements in glycemic control and near abolition of iatrogenic hypoglycemia.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651 · cited 1×
“score (minimum=0; maximum=7; no hypoglycemia=0; hypoglycemia unawareness≥4) (4) twice, including pre-ITx”
Froud, T., Ricordi, C., Baidal, D. A., Hafiz, M. M., Ponte, G., Cure, P., Pileggi, A., Poggioli, R., Ichii, H., Khan, A., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00957.x · Cited by 386 · cited 2×
“Procedures were performed as described (1) under protocols approved by the University of Miami health research ethics board and informed consent was obtained from each subject.”
BackgroundMethodSelf-citationPaty, B. W., Ryan, E. A., Shapiro, A. M. J., Lakey, J. R. T., & Robertson, R. P. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3428 · Cited by 154 · cited 2×
“Indeed, an improvement in hypoglycemia awareness following ITx was suggested by a small sample short-term clamp study (2), although the literature is not consistent (3).”
BackgroundKendall, D. M., Rooney, D. P., Smets, Y. F. C., Salazar Bolding, L., & Robertson, R. P. (1997) · Diabetes · doi:10.2337/diab.46.2.249 · Cited by 134 · cited 1×
“Pancreatic transplantation reestablishes normal glucose homeostasis (6), but the surgical risks are a limitation.”
BackgroundRickels, M. R., Schutta, M. H., Mueller, R., Kapoor, S., Markmann, J. F., Naji, A., & Teff, K. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2426 · Cited by 59 · cited 2×
“Indeed, an improvement in hypoglycemia awareness following ITx was suggested by a small sample short-term clamp study (2), although the literature is not consistent (3).”
BackgroundKendall, D. M., Rooney, D. P., Smets, Y. F. C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.2.249 · Cited by 38
(1996) · PubMed · Cited by 32
Cited by
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4127 · Cited by 412
Mechanisms of hypoglycemia unawareness and implications in diabetic patients
Martín-Timón, I. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.912 · Cited by 204
Lablanche, S., Vantyghem, M.-C., Kessler, L., Wojtusciszyn, A., Borot, S., Thivolet, C., Girerd, S., Bosco, D., Bosson, J.-L., Colin, C., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30078-0 · Cited by 200
Impaired awareness of hypoglycaemia: a review
Graveling, A. J., & Frier, B. M. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70470-5 · Cited by 160
Neuronal damage and cognitive impairment associated with hypoglycemia: An integrated view
Languren, G., Montiel, T., Julio-Amilpas, A., & Massieu, L. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.018 · Cited by 155
“Pancreas transplantation reduces the administration exogenous insulin, which in turn decreases the threat of iatrogenic hypoglycemia (Leitao et al., 2008).”
Lablanche, S., Borot, S., Wojtusciszyn, A., Bayle, F., Tétaz, R., Badet, L., Thivolet, C., Morelon, E., Frimat, L., Penfornis, A., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0094 · Cited by 122
“in allowing improvements in quality of life (7), metabolic control (4), prevention of hypoglycemic events (8), and protection of recipients against the progression of microangiopathy (9,10).”
BackgroundIslet assessment for transplantation
Papas, K. K., Suszynski, T. M., & Colton, C. K. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328332a489 · Cited by 110
“Islet cell transplantation (ICT) is emerging as a promising approach for the treatment of selected patients with type 1 diabetes mellitus [1–8].”
Islet Transplantation a Decade Later and Strategies for Filling a Half-Full Glass
Robertson, R. P. (2010) · Diabetes · doi:10.2337/db09-1846 · Cited by 104
Membranes to achieve immunoprotection of transplanted islets
Schweicher, J., Nyitray, C., & Desai, T. A. (2014) · Frontiers in bioscience · doi:10.2741/4195 · Cited by 99
“Nevertheless, clinical benefits are observed after islet transplantation even in the absence of insulin independence since the incidence of life-threatening hypoglycemia decreases dramatically(20).”
BackgroundIntraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye
Kim, J., Kim, J. J., Ku, M., Cha, E., Ju, S., Park, W. Y., Kim, K. H., Kim, D. W., Berggren, P., & Park, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03605 · Cited by 87
Forbes, S., Oram, R. A., Smith, A., Lam, A., Olateju, T., Imes, S., Malcolm, A. J., Shapiro, A. M. J., & Senior, P. A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13807 · Cited by 80
“There is growing consensus that the success of ITx should not be defined by the presence or absence of insulin independence but rather by maintenance of stable glycemic control and protection from severe hypoglycemia (2,4,9).”
BackgroundCross, S. E., Vaughan, R. H., Willcox, A. J., McBride, A. J., Abraham, A., Han, B., Johnson, J., Maillard, É., Bateman, P. A., Ramracheya, R. D., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13975 · Cited by 81
“Clinical pancreatic islet transplantation has undergone huge advances over the past decade, with up to 85% of selected patients remaining insulin-independent for at least a year post-transplantation in leading centres worldwide and the majority of transplanted patients achieving resolution of lifethreatening hypoglyca…”
BackgroundPoint: Steady Progress and Current Challenges in Clinical Islet Transplantation
Mineo, D., Pileggi, A., Alejandro, R., & Ricordi, C. (2009) · Diabetes Care · doi:10.2337/dc09-0490 · Cited by 79
“Notably, both the improvement in quality of life and the restoration of hypoglycemia awareness persist long term (23,27).”
BackgroundSelf-citationTowards xenotransplantation of pig islets in the clinic
Elliott, R. B. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283449dec · Cited by 66
Iqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 64
“In some individuals with severe recurrent hypoglycaemia and impaired hypoglycaemia awareness, referral for either islet cell or whole pancreatic transplantation may restore hypoglycaemia awareness (115).”
BackgroundDefective Counterregulation and Hypoglycemia Unawareness in Diabetes
Reno, C. M., Litvin, M., Clark, A. L., & Fisher, S. J. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.005 · Cited by 53
de Souza, B. M., Bouças, A. P., de Oliveira, F. D. S., Reis, K. P., Ziegelmann, P. K., Bauer, A. C., & Crispim, D. (2017) · Islets · doi:10.1080/19382014.2017.1286434 · Cited by 62
Lablanche, S., Borot, S., Wojtusciszyn, A., Skaare, K., Penfornis, A., Malvezzi, P., Badet, L., Thivolet, C., Morelon, E., Buron, F., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16637 · Cited by 50
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
Awoniyi, O., Rehman, R., & Dagogo-Jack, S. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0411-y · Cited by 59
Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice
Greenbaum, C., VanBuecken, D., & Lord, S. (2019) · Drugs · doi:10.1007/s40265-018-1035-y · Cited by 52
Restoration of Self-Awareness of Hypoglycemia in Adults With Long-Standing Type 1 Diabetes
Leelarathna, L., Little, S. A., Walkinshaw, E., Tan, H. K., Lubina-Solomon, A., Kumareswaran, K., Lane, A. P., Chadwick, T., Marshall, S. M., Speight, J., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1004 · Cited by 56
“Further support for this concept derives from recovery of IAH and defective counterregulation after eliminating recurrent hypoglycemia in people with insulinoma (13,14) and in people with T1D after pancreas (15,16) and islet cell transplantation (17), as well as through adherence to treatment protocols aimed at meticu…”
BackgroundPancreatic islet transplantation
Johnson, P., & Jones, K. E. (2012) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2012.05.012 · Cited by 52
Maharlooei, M. K., Hajizadeh‐Saffar, E., Tahamtani, Y., Basiri, M., Montazeri, L., Khalooghi, K., Ashtiani, M. K., Farrokhi, A., Aghdami, N., Nejad, A. S. H., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0094 · Cited by 50
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
“A retrospective cohort study reported a significantly reduced proportion of patients with impaired awareness of hypoglycaemia post-transplantation [140].”
BackgroundIslet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary?
Ludwig, B., Ludwig, S., Steffen, A., Saeger, H., & Bornstein, S. R. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0146-y · Cited by 48
“The Miami group could show that even patients with graft failure after islet transplantation showed significant less hypoglycemic episodes compared with pretransplant [ 26 ].”
ResultOvercoming barriers in clinical islet transplantation: Current limitations and future prospects
Chhabra, P., Sutherland, D. E. R., & Brayman, K. L. (2013) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.10.002 · Cited by 43
Rekittke, N. E., Ang, M., Rawat, D., Khatri, R., & Linn, T. (2016) · Stem Cells International · doi:10.1155/2016/3764681 · Cited by 41
“Severe hypoglycemic events can be prevented in islet recipients while C-peptide remained positive but may recur in those with failed grafts [16, 22] albeit less frequent than those prior to transplantation [26].”
Giménez, M., Lara, M., & Conget, I. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0028 · Cited by 38
“In absolute terms, and acknowledging the differences between both studies, the magnitude of restoration of hypoglycemia awareness achieved in our study using CSII is quite similar to that observed by Leita˜o et al. 31 using islet transplantation.”
Rheinheimer, J., Bauer, A. C., Silveiro, S. P., Estivalet, A. A. F., Bouças, A. P., da Rosa, A. R., de Souza, B. M., de Oliveira, F. S., Cruz, L. A., Brondani, L. D. A., et al. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000030 · Cited by 38
“As previously cited, one of the main limitations reported by most islet transplantation centers is a scarcity of BD donors (8).”
Background(2015) · PubMed · Cited by 37
Brain Death–Induced Inflammatory Activity in Human Pancreatic Tissue: A Case-Control Study
Rech, T. H., Crispim, D., Rheinheimer, J., Barkan, S. S., Osvaldt, A. B., Filho, T. D. J. M. G., Kruel, C. D. P., Martini, J., Gross, J. L., & Leitão, C. B. (2013) · Transplantation · doi:10.1097/tp.0b013e3182a949fa · Cited by 34
Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes
Reid, L. J., Baxter, F., & Forbes, S. (2021) · Diabetic Medicine · doi:10.1111/dme.14570 · Cited by 34
Ang, M., Meyer, C., Brendel, M. D., Bretzel, R. G., & Linn, T. (2013) · Diabetologia · doi:10.1007/s00125-013-3120-9 · Cited by 29
Exendin-4 protects rat islets against loss of viability and function induced by brain death
Carlessi, R., Lemos, N. E., Dias, A. L., de Oliveira, F. S., Brondani, L. D. A., Canani, L. H. S., Bauer, A. C., Leitão, C. B., & Crispim, D. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.009 · Cited by 29
“Improvement in glycemic control and hypoglycemia awareness are normally observed in patients transplanted with a sub-optimal islet mass (Leitao et al., 2008).”
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 26
Tekin, Z., Garfinkel, M. R., Chon, W. J., Schenck, L., Gołąb, K., Savari, O., Thistlethwaite, J. R., Philipson, L. H., Majewski, C., Pannain, S., et al. (2016) · Transplantation Direct · doi:10.1097/txd.0000000000000609 · Cited by 25
“The first and immediate advantage of islet cell transplantation was that patients became aware of hypoglycemia as soon as they achieved at least stable partial islet function with lower insulin requirements.(25,26) Obviously, subsequent insulin independence improved the ultimate outcome and lowered the risk-to-benefit…”
BackgroundForbes, S., McGowan, N. W. A., Duncan, K., Anderson, D., Barclay, J., Mitchell, D., Docherty, K., Turner, D. M., Campbell, J. D. M., & Casey, J. (2015) · Diabetologia · doi:10.1007/s00125-015-3554-3 · Cited by 23
“Allogeneic islet transplantation offers a minimally invasive option for beta cell replacement in people with type 1 diabetes complicated by recurrent severe hypoglycaemia and/or marked glycaemic lability [10], and results in improved awareness of hypoglycaemia [11].”
BackgroundImpaired Awareness of Hypoglycaemia
Frier, B. M. (2007) · Hypoglycaemia in Clinical Diabetes · doi:10.1002/9780470516270.ch7 · Cited by 22
Spiers, R. M., Marzi, J., Brauchle, E., Cross, S. E., Vaughan, R. H., Bateman, P. A., Hughes, S. J., Schenke‐Layland, K., & Johnson, P. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.013 · Cited by 21
“It has widely been demonstrated that this procedure can significantly improve glycaemic control in patients with T1DM [1-3], and in particular, resolve life-threatening hypoglycaemic unawareness [4].”
BackgroundAllo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Caldara, R., Tomajer, V., Monti, P., Sordi, V., Citro, A., Chimienti, R., Gremizzi, C., Catarinella, D., Tentori, S., Paloschi, V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323439 · Cited by 20
Successes and Disappointments with Clinical Islet Transplantation
Cravedi, P., van der Meer, I. M., Cattaneo, S. G. D. A., Ruggenenti, P. L., & Remuzzi, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_33 · Cited by 20
“Even patients with graft failure after islet transplantation showed significantly fewer hypoglycemic episodes compared with pretransplant (Leitao et al. 2008).”
ResultElliott, D., & Heller, S. R. (2011) · Practical Diabetes · doi:10.1002/pdi.1600 · Cited by 19
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 18
Kidney Donors With Diabetes: Renal Biopsy Findings at Time of Transplantation and Their Significance
Truong, L. D., Suki, W. N., Gaber, L. W., Gaber, A. O., & Khan, F. N. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000903 · Cited by 17
Takita, M., Matsumoto, S., Qin, H., Noguchi, H., Shimoda, M., Chujo, D., Itoh, T., Sugimoto, K., Onaca, N. N., Naziruddin, B., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x580617 · Cited by 16
Immunogenicity of β-cells for autologous transplantation in type 1 diabetes
Schuetz, C., & Markmann, J. F. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.003 · Cited by 15
Spiers, R. M., Cross, S. E., Brown, H. L., Bateman, P. A., Vaughan, R. H., Hughes, S. J., & Johnson, P. (2018) · Cell Transplantation · doi:10.1177/0963689718779778 · Cited by 14
Clinical intraocular islet transplantation is not a number issue.
Shishido, A., Caicedo, A., Rodriguez‐Diaz, R., Pileggi, A., Berggren, P., & Abdulreda, M. H. (2016) · PubMed · Cited by 14
Self-citationImpaired Awareness of Hypoglycaemia
Frier, B. M. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch6 · Cited by 14
Isolated pancreatic islet yield and quality is inversely related to organ donor age in rats
Gonzalez, N., Salgado, M., Medrano, L. J., Mullen, Y., & Komatsu, H. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110739 · Cited by 12
Cell Therapy for Type 1 Diabetes: From Islet Transplantation to Stem Cells
Sordi, V., Monaco, L., & Piemonti, L. (2022) · Hormone Research in Paediatrics · doi:10.1159/000526618 · Cited by 12
Kamel, J. T., Goodman, D. J., Howe, K., Cook, M. J., Ward, G. M., & Roberts, L. J. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2652 · Cited by 12
“These findings show, as previous studies have performed [4,5], that there is restoration of hypoglycaemia awareness after islet transplantation.”
BackgroundResultInfluentialHistory of islet transplantation
Digon, B. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0048-z · Cited by 10
“failure [ 32 ]. The further evolution of islet isolation and transplantation continues to be evaluated in multiple centers internationally, yet consistent problems must be overcome and continually addressed to make it an effective treatment [25].”
BackgroundPresent Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus
Chhabra, P., Clark, D. L., Daniel, J., & Kenneth, L. B. (2011) · InTech eBooks · doi:10.5772/22343 · Cited by 10
Delmonte, V., Peixoto, E. M. L., Poggioli, R., Enfield, G., Luzi, L., Ricordi, C., & Alejandro, R. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.01.031 · Cited by 9
Self-citationBrondani, L. D. A., Rech, T. H., Boelter, G., Bauer, A. C., Leitão, C. B., Eizirik, D. L., & Crispim, D. (2016) · Transplantation · doi:10.1097/tp.0000000000001292 · Cited by 7
Clinical Trials with Stem Cell-Derived Insulin-Producing Cells
Lei, J., & Markmann, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_23 · Cited by 6
Impact of Anti–Insulin Antibodies on Islet Transplantation Outcome: Data From the GRAGIL Network
Lablanche, S., Borot, S., Thaunat, O., Bayle, F., Badet, L., Morélon, E., Thivolet, C. H., Wojtusciszyn, A., Frimat, L., Kessler, L., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000081 · Cited by 5
“Islet transplantation allows to improve the quality of life and metabolic control (1), to prevent hypoglycemic events (2), to protect against the progression of microangiopathy (3, 4), and to obtain insulin independence in more than 50% of patients at 5 years in experienced centers (1, 5).”
BackgroundEffect of Exenatide on Gastric Emptying and Graft Survival in Islet Allograft Recipients
Peixoto, E. M. L., Froud, T., Gomes, L. S., Mireles-Zavala, L., Corrales, A., Herrada, E., Ricordi, C., & Alejandro, R. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.10.022 · Cited by 5
Self-citationIslet Cell Therapy and Pancreatic Stem Cells
Domínguez‐Bendala, J., Pileggi, A., & Ricordi, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00070-6 · Cited by 5
Self-citationIslet Cell Therapy and Pancreatic Stem Cells
Domínguez‐Bendala, J., Pileggi, A., & Ricordi, C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10023-9 · Cited by 4
Self-citationSuccesses and Disappointments with Clinical Islet Transplantation
Cravedi, P., Ruggenenti, P. L., & Remuzzi, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-6884-0_23-1 · Cited by 3
Islet and Pancreas Transplantation
Mineo, D., Ciancio, G., Burke, G., Alejandro, R., & Ricordi, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_23 · Cited by 5
“Yet, significant metabolic improvements are maintained even with only partial islet graft function, such as stability of glucose control with normalized HbA1c, amelioration of insulin sensitivity with reduced insulin requirements, lack of severe hypoglycemia with restored hypoglycemia awareness, and improved quality o…”
BackgroundSelf-citationKomatsu, H., Kobayashi, E., Gonzalez, N., Rawson, J., Ortiz, J., Donohue, C., Ku, H. T., KANDEEL, F. R., & Mullen, Y. (2022) · Pancreas · doi:10.1097/mpa.0000000000002004 · Cited by 3
Tissue-engineered islet graft design and assessment
Suszynski, T. M. (2012) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 3
Islet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_23 · Cited by 2
Chen, S., Wu, P., Zhang, T., Zhang, J., & Gao, H. (2024) · Medicine · doi:10.1097/md.0000000000037945 · Cited by 2
“[45]”
Eligibility of patients with type 1 diabetes for islet transplantation alone
Berney, T., Ahmed, M. A., Gastaldi, G., & Andrès, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00033-2 · Cited by 2
Progress toward islet transplantation tolerance
Markmann, J. F., & Rickert, C. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00058-7 · Cited by 2
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_19 · Cited by 2
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Chhabra, P., & Brayman, K. L. (2020) · OBM Transplantation · doi:10.21926/obm.transplant.2004125 · Cited by 2
Islet Cell or Pancreas Transplantation
Piemonti, L., Socci, C., Nano, R., Maffi, P., & Secchi, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_23-1 · Cited by 2
Authesserre, C. (2016) · theses.fr (ABES) · doi:10.70675/5a15839fz9657z40ccz840czf6583c34ba39 · Cited by 2
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_19 · Cited by 1
Allotransplantation of Pancreatic Islets
Juszczak, M. T., & Johnson, P. (2012) · Wiley eBooks · doi:10.1002/9781118483664.ch6 · Cited by 1
Beta Cell Transplantation and Regeneration
Weir, G. C., & Gaglia, J. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00050-0 · Cited by 1
Islet and Pancreas Transplantation
Mineo, D., Ciancio, G., Burke, G. W., Alejandro, R., & Ricordi, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-366-4_2 · Cited by 1
Self-citationRheinheimer, J., Leitão, C. B., Rohde, C. M., Rech, T. H., Kramer, C. K., Steemburgo, T., Barkan, S. S., Filho, T. D. J. M. G., Kruel, C. D. P., Osvaldt, A. B., et al. (2011) · Clinical & Biomedical Research · Cited by 1
Hypoglycaemia in the treatment of diabetes mellitus
Choudhary, P., & Amiel, S. A. (2011) · doi:10.1093/med/9780199235292.003.1435 · Cited by 1
Berney, T., Andrès, A., Wassmer, C., & Berishvili, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_84 · Cited by 1
Whole Pancreas and Islet Cell Transplantation
Marfil‐Garza, B. A., Senior, P. A., & Shapiro, A. M. J. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch34 · Cited by 1
Giménez, M. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Insel(zell)transplantation bei Typ-1-Diabetes-mellitus
Schmid, J., Ludwig, B., & Brendel, M. D. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0731-y · Cited by 1
Islet Xenotransplantation: toward a cure for diabetes
van der Windt, D. J. (2011)
Endocrine Therapeutic Delivery
Fung, M., Thompson, D., Paty, B. W., Warnock, G. L., Ao, Z., Meloche, M. R., Shapiro, R. J., Keown, P. A., Ho, S. G. F., Vechere, B., et al. (2014) · Wiley eBooks · doi:10.1002/9781118903681.ch7
Líneas de investigación en el trasplante de islotes pancreáticos
Zapata-Garrido, A. J., & Trujillo-Murillo, K. D. C. (2010) · El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León)
Insel(zell)-Transplantationen bei Typ-1-Diabetes-Patienten
Brendel, M. D., Ludwig, B., Eckhard, M., & Bretzel, R. G. (2010) · Der Diabetologe · doi:10.1007/s11428-010-0561-3
Reversal of Diabetes: Islet Cell Transplantation
Pileggi, A., Alejandro, R., & Ricordi, C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_16
“12), and the absence of severe hypoglycemic episodes, even when patients are still treated with exogenous insulin due to partial graft function [ 97, 104, 105 ] .”
BackgroundSelf-citationAn Overview of the Experimental Islet Isolation In Human Pancreas
Gürol, A. O., Kursun, Kasapoglu, Aydın, B., Cu, A., Özdemir, A., Çevik, A., Kucuk, M., Cakiris, A., Uc, K., et al. (2015) · doi:10.15436/2471-5891.15.506
Hypoglycaemia in children and adults with type 1 diabetes: clinical implications
Graveling, A. J. (2015) · ERA
Spiers, R. M. (2019) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-konr68ajj
Thérapeutique des désordres glycémiques
Monnier, L., & Colette, C. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-73954-5.00007-x
Pancreatic and Islet Transplantation
Weir, G. C., & Gaglia, J. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00050-2
Islet Transplantation in Type 1 Diabetes Mellitus With Hypoglycaemic Unawareness
Agarwal, G., & Cross, S. (2020) · Journal of the Nuffield Department of Surgical Sciences · doi:10.37707/jnds.v1i4.74
Kamel, J. T. (2020) · Minerva Access (University of Melbourne)
Thérapeutique des désordres glycémiques
(2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00007-5
Current literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.973
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_19-1
Metadata
- Authors
- Leitão, C. B., Tharavanij, T., Cure, P., Pileggi, A., Baidal, D. A., Ricordi, C., & Alejandro, R.
- Affiliations
- Diabetes Research Institute, Miami, Florida
- University of Miami (US)
- Corresponding author
- Alejandro, Rodolfo
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 31
- Issue
- 11
- Pages
- 2113-2115
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2571057
- OpenAlex
- W2151487860
- Cited by
- 101
- References
- 6
- Citations by year
- 2024: 2 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 8 · 2018: 4 · 2017: 2 · 2016: 7 · 2015: 15 · 2014: 6 · 2013: 14 · 2012: 5
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk056953-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK056953, 5R01 DK 55347, R01DK055347, 5R01DK056953)
- National Center for Research Resources (M01RR016587, M01‐RR16587, U42RR016603)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- islet transplantation, hypoglycemia awareness, hypoglycemia unawareness, type 1 diabetes, islet graft function, islet graft failure, graft dysfunction, C-peptide, metabolic control
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemia, Male, Middle Aged, Retrospective Studies, Cohort Studies, Islets of Langerhans Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.